CAVAGNA, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 2.951
EU - Europa 1.979
AS - Asia 1.123
AF - Africa 6
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.071
Nazione #
US - Stati Uniti d'America 2.922
CN - Cina 1.074
IE - Irlanda 906
FI - Finlandia 265
UA - Ucraina 205
DE - Germania 193
IT - Italia 183
SE - Svezia 76
AT - Austria 56
GB - Regno Unito 36
IN - India 30
CA - Canada 28
FR - Francia 23
BE - Belgio 19
IL - Israele 4
MK - Macedonia 4
PT - Portogallo 4
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
EC - Ecuador 3
HK - Hong Kong 3
NL - Olanda 3
DK - Danimarca 2
DZ - Algeria 2
MU - Mauritius 2
NG - Nigeria 2
RU - Federazione Russa 2
AM - Armenia 1
BO - Bolivia 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
IQ - Iraq 1
JP - Giappone 1
MX - Messico 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
Totale 6.071
Città #
Dublin 891
Chandler 770
Jacksonville 324
Nanjing 286
Ashburn 242
Princeton 160
Lawrence 140
Helsinki 135
Wilmington 125
Nanchang 115
Beijing 113
Medford 104
Shenyang 87
Hebei 80
Jiaxing 77
Changsha 76
Shanghai 62
Ann Arbor 55
New York 55
Tianjin 55
Vienna 52
Pavia 50
Hangzhou 49
Milan 39
Boardman 31
Woodbridge 31
Norwalk 27
Pune 23
Seattle 22
Fairfield 20
Toronto 19
Brussels 18
Washington 17
Redwood City 11
Verona 11
Houston 10
San Francisco 9
Chicago 7
Auburn Hills 6
Guangzhou 6
Jinan 6
Ningbo 6
Ottawa 5
Berlin 4
Borås 4
Chaozhou 4
Dearborn 4
Lanzhou 4
Redmond 4
Tel Aviv 4
Zhengzhou 4
Changchun 3
Chengdu 3
Des Moines 3
Esslingen am Neckar 3
Falls Church 3
Lisbon 3
Moncalieri 3
Napoli 3
Orange 3
Quito 3
San Giuliano Milanese 3
Settimo Torinese 3
Abuja 2
Aosta 2
Bulgorello 2
Canberra 2
Canyon Country 2
Castelbuono 2
Collegno 2
Conegliano 2
Cupertino 2
Davis 2
Frankfurt am Main 2
Fremont 2
Fuzhou 2
Genova 2
Gunzenhausen 2
Haikou 2
Hyderabad 2
Kunming 2
Lodi 2
Rome 2
Tizi Ouzou 2
Turin 2
Vanzago 2
Aachen 1
Addison 1
Andover 1
Atlanta 1
Baghdad 1
Biella 1
Birr 1
Bolano 1
Bologna 1
Brunssum 1
Cedar Knolls 1
Chongqing 1
Costa Mesa 1
Den Haag 1
Totale 4.555
Nome #
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 89
Interessamento cutaneo nella dermatomiosite 84
Association between anti-dsDNA titre increase and thymoma relapse 78
A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: a challenging clinical case in light of the current diagnostic criteria. 75
Spondiliti e spondilodisciti batteriche. 71
2-DE and LC-MS/MS for a Comparative Proteomic Analysis of BALf from Subjects with Different Subsets of Inflammatory Myopathies 71
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 69
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. 68
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 65
Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. 64
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 64
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 63
Early electroretinografic changes in elderly RA patients treated with hydroxychloroquine 61
Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) 61
Overuse of prescription and otc non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis and osteoarthritis. 60
Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjogren syndrome 60
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 59
La poliangioite microscopica. 58
Effects of anti-TNF alpha drugs on disability in patients with rheumatoid arthritis: Long-term real-life data from the Lorhen registry 56
Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial 56
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome 56
A case of adult onset Still's disease treated with infliximab - Reply 56
Rheumatoid arthritis and renal light-chain deposition disease: long-term effectiveness of TNF-alpha blockade with etanercept 55
Pain in arthritis 55
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. 55
Therapeutic options in Anti-Jo1 antisynthetase syndrome with interstitial lung disease. 55
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. 54
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 54
Compressive cervical myelopathy due to massive periodontoid calcium pyrophosphate crystal deposition 53
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy 53
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 53
Biosimilars: Lights and shadows in rheumatology 53
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 53
Is it really infective endocarditis? Distinguishing systemic vasculitis from its mimics 53
Cardiovascular involvement in rheumatoid arthritis [L'interessamento cardiaco nell'artrite reumatoide] 52
Performance of classification criteria for gout in early and established disease 51
"Emergency" Cochlear Implantation in Labyrinthitis Ossificans Secondary to Polyarteritis Nodosa: How to Face a Rare Entity 51
Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated 51
Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis. 50
Pulmonary arterial hypertension in antisynthetase syndrome: comment on the article by Chatterjee and Farver. 50
Pain and rheumatology: An overview of the problem 50
Undiagnosed connective tissue diseases High prevalence in pulmonary arterial hypertension patients 50
Biotechnological drugs: The breakthrough in autoimmune rheumatic conditions 50
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 50
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 50
Therapy of necrotizing arteritis | [La terapia delle vasculiti necrotizzanti] 49
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 49
Chromosomally integrated human herpesvirus 6 in a patient with systemic lupus erythematosus. 48
Study for updated gout classification criteria: Identification of features to classify gout 48
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 48
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: The effect of rofecoxib withdrawal 47
Modulating the co-stimulatory signal for T cell activation in rheumatoid arthritis: Could it be the first step of the treatment? 47
Atherosclerosis and rheumatoid arthritis: more than a simple association 47
Clinical spectrum time course of interstitial pneumonia with autoimmune features in patients positive for antisynthetase antibodies 47
Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. 47
Brief Report: Validation of a Definition of Flare in Patients With Established Gout 46
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine 46
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 46
Clinical spectrum of anti-Jo-1-associated disease 46
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 45
New perspectives in the classification and treatment of systemic lupus erythematosus: the central role of kidney involvement] [Nuovi aspetti classificativi e terapeutici del lupus eritematoso sistemico: centralità dell'interessamento renale] 45
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 45
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 45
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 45
The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: A Retrospective population-based study in Southern Italy 44
Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study 44
Telemedicine: a useful tool but not the holy grail. Response to: 'Telemedicine will not keep us apart in the COVID-19 pandemic' by Perniola et al 44
Cobalt hip prosthesis intoxication mimicking an autoimmune disease 44
One year in review 2019: idiopathic inflammatory myopathies 43
Rheumatoid arthritis in beta-thalassemic trait: clinical, serologic and immunogenetic profile. 42
Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis 42
Miositi idiopatiche dell’adulto: analisi retrospettiva di 45 casi. 41
Clinical and electrophysiological evaluation of peripheral neuropathy in rheumatoid arthritis 41
Long-term safety of abatacept in patients with rheumatoid arthritis 41
New criteria needed for antisynthetase syndrome 41
Idiopathic inflammatory myopathies: Narrative review of unmet needs in clinical practice guidelines 41
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 41
Sinonasal Surgery in Wegener's Granulomatosis: Is It Time to Go On? 40
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases 40
Infliximab in the treatment of adult Still's disease refractory to conventional therapy 40
Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis 40
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 40
Genetics and novel aspects of therapies in systemic lupus erythematosus 39
Thrombocytopenia in idiopathic inflammatory myopathies: a case series analysis 39
CT-guided biopsy in the differential diagnosis of Sjogren syndrome associated cystic lung disease: A case of lung nodular AL-k amyloidosis 39
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 38
Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study 38
Pulmonary nocardiosis in a patient affected by anti-MDA5-positive amyopathic dermatomyositis under immunosuppressive therapy 37
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 37
Colony-stimulating factor-1: A potential biomarker for lupus nephritis 36
Polyarthrite rhumatoïde associée à un trait bêta-thalassémique : aspect clinique, sérologique et immunogénétique 36
One year in review 2018: idiopathic inflammatory myopathies 36
Capillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab 35
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 35
Combined ultrasound–CT approach to monitor acute exacerbation of interstitial lung disease 34
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 34
Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay 33
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course 33
Survey definitions of gout for epidemiological studies: Comparison with crystal identification as the gold standard 32
Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis 32
Totale 4.923
Categoria #
all - tutte 26.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 8 2 5
2019/20201.181 348 485 5 39 3 44 17 60 13 99 65 3
2020/2021512 45 35 17 46 14 55 2 92 52 66 68 20
2021/2022745 36 23 30 6 17 14 22 45 35 9 105 403
2022/20232.425 270 193 32 194 195 194 5 149 1.076 10 56 51
2023/2024881 109 196 38 60 66 267 38 61 6 40 0 0
Totale 6.422